CREDIT SUISSE AG/ - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 91 filers reported holding OVID THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$33,000
-5.7%
14,568
+24.0%
0.00%
Q1 2020$35,000
-96.9%
11,746
-95.7%
0.00%
-100.0%
Q4 2019$1,129,000272,1640.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,252,892$10,930,0004.97%
GLOBEFLEX CAPITAL L P 1,397,770$4,697,0001.02%
BVF INC/IL 6,631,051$22,280,0000.87%
EcoR1 Capital, LLC 6,082,200$20,436,0000.71%
Ikarian Capital, LLC 1,105,082$3,715,0000.26%
CHI Advisors LLC 233,510$785,0000.23%
DCF Advisers, LLC 141,701$476,0000.21%
Artal Group S.A. 2,500,000$8,400,0000.19%
PLATINUM INVESTMENT MANAGEMENT LTD 766,901$2,577,0000.07%
ACADIAN ASSET MANAGEMENT LLC 1,903,162$6,394,0000.02%
View complete list of OVID THERAPEUTICS INC shareholders